Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Neurodegenerative Disease Management is Scopus-indexed (Q2, CiteScore 4.7), WoS ESCI. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 1758-2024Verify ISSN ↗1758-2032Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Neurology (clinical) | 142 / 403 | 64th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2014–present, best quartile Q2, CiteScore 4.7.
Neurodegenerative Disease Management is Q2 in Neurology (clinical) (rank 142 of 403), by CiteScore 2025.
Neurodegenerative Disease Management is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.7, which places it in quartile Q2 at the 64th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.804, quartile Q2, with an H-index of 38.
Neurodegenerative Disease Management is published by Taylor and Francis Ltd. Its print ISSN is 1758-2024 and its online ISSN is 1758-2032.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Neurodegenerative Disease Management has an h-index of 48 and a 2-year mean of 1.75 citations per paper (OpenAlex). Its Scopus CiteScore is 4.7, quartile Q2. On 2-year citations it ranks #182 of 403 Scopus journals in Neurology (clinical).
Neurodegenerative Disease Management published 85 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2025–2026), authors are most often from United States (19.9%), India (9.9%) and China (9.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.